IAIlir Alimehmeti

Ilir Alimehmeti

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ilir Alimehmeti has a total of 22 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Sheep-associated Escherichia coli in Albania show high genomic similarity to European ovine lineages and a conserved core resistome

    by Maitiú Marmion, Christina Killian, Tristan Russell, Guerrino Macori, Ilir Alimehmeti, Xhelil Koleci, Séamus Fanning

    Sheep and sheep products play a notable role in Albanian culture and economy, particularly in rural regions. This sector is defined by small-scale activities and often faces challenges linked to safety and productivity. These issues necessitate the development of reforms to protect public health, boost productivity, and comply with regulatory requirements. Escherichia coli is a frequent ovine commensal, with an association with pathotypes like Shiga Toxin-encoding E. coli. The relationship between ovine bacteria and antibiotic resistance further remains poorly characterized. In this study, E. coli isolates from sheep across Albania were sequenced using Oxford Nanopore Technologies™ and characterized in silico for serotype, virulence, resistance genes, and phylogenetic relationships as isolates were compared to a global collection of animal and environmentally associated genomes. Isolates exhibited diverse serotypes and a conserved resistome comprising four genes, including EC-type β-lactamases. Four isolates were Shiga toxin-positive (stx1c predominant). Phylogenetic analyses revealed high similarity with European ovine E. coli, indicating regional relatedness and potential for resistance gene dissemination. This work provides the first genomic insight into ovine E. coli in Albania and highlights their potential role in antimicrobial resistance dynamics within livestock systems. These findings are crucial to understand for the development of Albanian agricultural practices.


  • Open Access

    Hospitalizations and in-hospital outcomes in patients with ST-elevation myocardial infarction during the coronavirus disease 2019 pandemic: The Albanian experience

    by Leonard Simoni, Ilir Alimehmeti, Mirald Gina, Astrit Ceka, Ermir Tafaj, Alban Dibra, Artan Goda, Tirana Albania

    Objective: Global studies report a significant decline in ST-elevation myocardial infarction (STEMI) related hospitalization rates during the coronavirus disease 2019 (COVID-19) pandemic outbreak. However, there have been several divergent reports on hospital outcomes. In this study, we aim to investigate the impact of the COVID 19 outbreak on hospitalizations because of STEMI and in-hospital outcomes in Albania. Methods: This was a retrograde study, collecting data for hospitalizations because of STEMI from March 9, (first COVID 19 case in our country) to April 30, 2020, (period of total lockdown) compared with the same period in 2019 at our center. The incidence rate ratio (IRR) was used to compare admissions because of STEMI and procedures and the risk ratio (RR) to compare mortality and other complication rates. Results: Admissions for STEMI declined during the COVID-19 period from a total of 217 in 2019 to 156 in 2020 (-28.1%) representing IRR 0.719 (p=0.033). PCIs also reduced from 168 procedures in 2019 to 113 in 2020 (-33%), representing an IRR of 0.67, p=0.021. The time from symptom onset to arrival at our intensive care unit was significantly higher in 2020 compared to 2019 (925.6 +/- 1097 vs. 438.7 +/- 385 minutes, p<0.001). The STEMI death rate during the pandemic compared to the control period was significantly increased to 14.1% vs. 7.8% (RR=1.91 p=0.037, but with no significant increase in primary PCI-STEMI death rate (8.9% vs. 4.8% RR=1.85 p=0.217). Cardiogenic shock also increased during the pandemic to 21.2% from 12.4% in 2019 (RR=1.70 p=0.025). Conclusion: Hospitalizations and revascularization procedures for STEMI significantly reduced during the COVID-19 pandemic. We identified a substantial increase in the STEMI mortality rate and cardiogenic shock during the pandemic outbreak. Delayed timely reperfusion intervention might be responsible for the increased risk for complications.


  • Open Access

    Impact of coronavirus disease 19 (COVID 19) pandemic on acute coronary syndrome (ACS) hospitalizations, and related invasive procedures

    by L Simoni, I Alimehmeti, A Ceka, E Tafaj, M Gina, A Dibra, A Goda

    Funding Acknowledgements: Type of funding sources: None. Background: Reports from countries affected by the COVID 19 pandemic demonstrate a reduction in ACS hospitalizations and invasive procedures. Purpose: We aimed to investigate the impact of the COVID 19 pandemic on ACS patient hospitalizations and related invasive procedures in a country with low COVID 19 incidence and without changes in Cardiology hospital services. Methods: We conducted a retrograde study collecting data for ACS hospitalizations including ST elevation myocardial infarction (STEMI), non- ST elevation myocardial infarction (NSTEMI) and unstable angina (UA) and related invasive and revascularization procedures from March 9th 2020 (first COVID 19 case in our country) to April 30th (period of total lockdown) compared with the same period of 2019 in our center. Results: Hospital admissions for ACS declined during 2020 (COVID 19 period) from a total of 550 patients in 2019 to 321 patients hospitalization in 2020 representing a 41.6% reduction (p < 0.001). The reduction was observed for all types of ACS, the greatest reduction was for UA 58% (p < 0.001) followed by NSTEMI 32% (p < 0.001) and for STEMI 28% reduction (p < 0.009). Compared to 2019 the proportion of patients presented with STEMI was higher in 2020 (48.6% vs 39.5% p = 0.01) and lower with UA (43.3% vs 31.5% p = 0.0002) Reduction was observed also in coronary angiography by 43% (p < 0.001) and in percutaneous coronary interventions with 42% (p < 0.001). Compared to 2019 the proportion of patients with 3 vessels coronary disease(CAD)and left main (LM) was higher during COVID 19 pandemic, respectively 33% vs 40% p = 0.032 and 8% vs 13% p = 0.046 Conclusions: Hospitalizations and related invasive procedures for ACS significantly dropped during COVID 19 pandemic. Patients admitted to hospital during pandemic presented more with STEMI and had more 3 vessels CAD and LM. Measures should be taken to ensure patients for the safety of health services and encouraged not to neglect cardiac consultations and treatments.


  • Open Access

    Acute Myocarditis: A Rare Complication after Black Widow Spider Bite

    by Uhc “Mother Theresa” Addictology And Clinical Toxicology Service, Irena Çeko Marko, Enkeleida Gjiçali, Sonil Marko, Ilir Alimehmeti, Zihni Sulaj

    Black widow spider bite can be a rare condition causing various symptoms from mild to very dramatic ones. In this article, we describe the case of a young girl bitten by a black spider whose evaluation was complicated by fulminant myocarditis, fortunately with a good prognosis. Our case study brings light to the various effects that toxins released from the black widow spider can have on the body, especially on the heart. Myocarditis can be one such clinical complication caused due to the effect of the toxic agent on the heart muscle.


  • Open Access

    Anaphylactic Reactions due to Snakebite Vipera and Administration of Antivenom

    by Irena Çeko Marko, Uhc “Mother Theresa” Addictology & Clinical Toxicology Service, Sonil Marko, Ilir Alimehmeti, Zihni Sulaj

    A venomous snakebite is the single most important global cause of human injury from venomous and poisonous animals of all types. The viper family (Viperaberus, Viperaammodites, Viperaursine) is the 2nd most important venomous snake family of major medical importance globally and they are found in Albania. All have mobile fangs in the front of the mouth on hinged maxillae, allowing the fangs to fold away against the roof of the mouth when not in use.